APRIL (protein)

From WikiMD's WELLNESSPEDIA

APRIL (protein) also known as A Proliferation-Inducing Ligand, is a member of the tumor necrosis factor (TNF) superfamily. It is a protein that in humans is encoded by the TNFSF13 gene. APRIL is involved in various cellular processes, including cell proliferation, differentiation, apoptosis, and immune regulation.

Function[edit]

APRIL is a cytokine that belongs to the tumor necrosis factor superfamily. This cytokine is known to stimulate the proliferation of T cells and lymphocytes, and induce apoptosis in certain tumor cells. This cytokine is also reported to be involved in the regulation of B-cell maturation, antibody production, and immune response, and is particularly important in autoimmune diseases and cancer.

Structure[edit]

APRIL is a type II transmembrane protein, which means it is anchored in the cell membrane with its N-terminus inside the cell and its C-terminus outside. The extracellular portion of APRIL contains the functional part of the protein, which can be cleaved off and secreted as a soluble molecule.

Clinical significance[edit]

APRIL has been found to be overexpressed in many types of cancer, including breast cancer, colorectal cancer, and non-Hodgkin lymphoma. It is thought that the overexpression of APRIL may contribute to the survival and proliferation of cancer cells, making it a potential target for cancer therapy.

In autoimmune diseases, APRIL has been found to be involved in the production of autoantibodies, which are antibodies that attack the body's own tissues. This makes APRIL a potential target for the treatment of autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus.

See also[edit]

References[edit]


External links[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.